ASOP Global Releases Survey Noting Consumers Are Increasingly Purchasing Medications Through Online Pharmacies
The Alliance for Safe Online Pharmacies (ASOP Global) has released a survey that shows Americans are increasingly purchasing medications through online pharmacies. Based on the perceptions of 1,500 American consumers, 69% of Americans said they felt comfortable being prescribed a controlled substance (CS) by a health care professional who they met only through telehealth appointments. […]
Read More ›HHS Publishes Resource for Health Care Providers About Protecting Patients’ Health Information When Using Telehealth
The United States Department of Health and Human Services (HHS) has published two resources aimed at educating health care providers and patients about the privacy and security risks to their protected health information when using telehealth services. Health care providers are not required by the Health Insurance Portability and Accountability Act to educate patients on […]
Read More ›NABP President Newsome Highlights Mental Health concerns in Address to the Pharmacy Community
NABP has released a video from NABP President Lenora S. Newsome, PD, in which she discusses her presidential initiative addressing the critical issue of mental health and well-being in the practice of pharmacy. In the heartfelt video message, Dr Newsome, a devoted southern Arkansas pharmacist with 43 years of experience, expresses her deep concern for […]
Read More ›Over 99% of Health Care System Pharmacists Surveyed Report Experiencing Drug Shortages
Over 99% of health care system pharmacists report experiencing drug shortages, according to a quarterly survey by American Society of Health-System Pharmacists (ASHP). Out of the 1,123 pharmacists who responded to the ASHP survey, nearly a third of participants labeled the shortage as “critically impactful,” causing health care professionals to delay, ration, or cancel treatments […]
Read More ›Final Guidance for Trading Partners to Adopt Secure Electronic Data Exchange System Released by FDA
Food and Drug Administration (FDA) has released a final guidance clarifying the necessary standards to adopt secure, interoperable electronic data exchange among the pharmaceutical distribution supply chain. Specifically, the DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs – Guidance for Industry document offers recommendations for trading partners […]
Read More ›Approximately $9 Million Provided to Rural Communities to Increase Number of Substance Use Disorder Clinicians, According to HHS
The United States Department of Health and Human Services (HHS), through the Health Resources and Services Administration, reports that $9 million was awarded from the Biden-Harris Administration to strengthen mental health and expand substance use services in underserved communities. The funds will train additional health care providers to provide care for individuals and families in […]
Read More ›Universities in South Carolina Initiate Program to Advance AI in Health Care
Universities and colleges in South Carolina are joining a federally funded, Clemson University-led coalition focused on advancing artificial intelligence (AI) technology in health care diagnostics and treatment. Funded by the National Science Foundation, the program is called Artificial Intelligence-Enabled Devices for the Advancement of Personalized and Transformative Health Care in South Carolina. In addition to […]
Read More ›Narcan Nasal Spray Becomes an OTC Drug
Food and Drug Administration (FDA) approved the Narcan® 4 mg naloxone hydrochloride nasal spray to be sold over-the-counter (OTC), making it the first naloxone product that will be available without a prescription. Naloxone is a life-saving medication that reverses the effects of opioid overdoses. The product will include instructions for consumers regarding how to use […]
Read More ›Importation of Xylazine Restricted Due to Increasing Public Health Concern
Food and Drug Administration (FDA) announced that it is restricting the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage form drug products into the United States to address growing concerns of the chemical appearing in drugs such as illicitly manufactured fentanyl, methamphetamine, and cocaine. The agency warns that individuals who inject products containing […]
Read More ›FDA Launches New Dietary Supplement Ingredient Directory
Food and Drug Administration (FDA) launched its new Dietary Supplement Ingredient Directory, which is a database that lists the ingredients used in products marketed as “dietary supplements” and FDA’s actions taken and statements made in response to those ingredients. The agency will update the directory periodically to show recent developments. FDA notes that additional feedback […]
Read More ›